• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Screening for ovarian cancer: a systematic review.

作者信息

Bell R, Petticrew M, Luengo S, Sheldon T A

机构信息

NHS Centre for Reviews and Dissemination, University of York, UK.

出版信息

Health Technol Assess. 1998;2(2):i-iv, 1-84.

PMID:9561894
Abstract
摘要

相似文献

1
Screening for ovarian cancer: a systematic review.卵巢癌筛查：一项系统评价
Health Technol Assess. 1998;2(2):i-iv, 1-84.
2
The potential and problems of screening for ovarian cancer.卵巢癌筛查的潜力与问题
Eur J Gynaecol Oncol. 2005;26(3):241-3.
3
Specific keynote: ovarian cancer risk assessment and the potential for early detection.专题 keynote：卵巢癌风险评估及早期检测的可能性。
Gynecol Oncol. 2003 Jan;88(1 Pt 2):S75-9; discussion S80-3. doi: 10.1006/gyno.2002.6689.
4
Sensitivity and specificity of multimodal and ultrasound screening for ovarian cancer, and stage distribution of detected cancers: results of the prevalence screen of the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS).多模式及超声筛查卵巢癌的敏感性和特异性，以及所检测癌症的分期分布：英国卵巢癌筛查协作试验（UKCTOCS）患病率筛查结果
Lancet Oncol. 2009 Apr;10(4):327-40. doi: 10.1016/S1470-2045(09)70026-9. Epub 2009 Mar 11.
5
Screening for ovarian cancer. We now need a definitive randomised trial.卵巢癌筛查。我们现在需要一项权威性的随机试验。
BMJ. 1999 Nov 20;319(7221):1317-8. doi: 10.1136/bmj.319.7221.1317.
6
Estimating Cost-effectiveness of a Multimodal Ovarian Cancer Screening Program in the United States: Secondary Analysis of the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS).美国多模式卵巢癌筛查计划的成本效益评估：英国卵巢癌筛查协作试验（UKCTOCS）的二次分析。
JAMA Oncol. 2018 Feb 1;4(2):190-195. doi: 10.1001/jamaoncol.2017.4211.
7
The value of ovarian cancer screening.
Br J Hosp Med (Lond). 2006 Jun;67(6):314-7. doi: 10.12968/hmed.2006.67.6.21292.
8
The role of CA 125 in screening for ovarian cancer.CA 125在卵巢癌筛查中的作用。
Int J Biol Markers. 1998 Oct-Dec;13(4):216-20. doi: 10.1177/172460089801300408.
9
CA 125 as a screening test for ovarian cancer.癌抗原125作为卵巢癌的筛查检测
J Med Screen. 1996;3(1):40-2. doi: 10.1177/096914139600300110.
10
[Program for early detection of ovarian cancer for women as prophylaxis provided at a municipal hospital].[市立医院为女性提供的作为预防措施的卵巢癌早期检测项目]
Wiad Lek. 2004;57 Suppl 1:43-7.

引用本文的文献

1
Genome-Wide cfDNA Methylation Profiling Reveals Robust Hypermethylation Signatures in Ovarian Cancer.全基因组cfDNA甲基化分析揭示卵巢癌中强大的高甲基化特征
Cancers (Basel). 2025 Jun 17;17(12):2026. doi: 10.3390/cancers17122026.
2
Assessing the rates of false-positive ovarian cancer screenings and surgical interventions associated with screening tools: a systematic review.评估与筛查工具相关的卵巢癌假阳性筛查率及手术干预率：一项系统评价
BMJ Oncol. 2024 Jul 18;3(1):e000404. doi: 10.1136/bmjonc-2024-000404. eCollection 2024.
3
Epidemiology and risk factors for ovarian cancer.
卵巢癌的流行病学及危险因素
Prz Menopauzalny. 2023 Jun;22(2):93-104. doi: 10.5114/pm.2023.128661. Epub 2023 Jun 14.
4
Early diagnosis of ovarian cancer based on methylation profiles in peripheral blood cell-free DNA: a systematic review.基于外周血游离 DNA 甲基化谱的卵巢癌早期诊断：系统评价。
Clin Epigenetics. 2023 Feb 14;15(1):24. doi: 10.1186/s13148-023-01440-w.
5
Physician Nonprofessional Cancer Experience and Ovarian Cancer Screening Practices: Results from a National Survey of Primary Care Physicians.非专业医师的癌症经验与卵巢癌筛查实践：来自初级保健医师全国性调查的结果。
J Womens Health (Larchmt). 2018 Nov;27(11):1335-1341. doi: 10.1089/jwh.2018.6947. Epub 2018 Aug 10.
6
Molecular Characterization of Epithelial Ovarian Cancer: Implications for Diagnosis and Treatment.上皮性卵巢癌的分子特征：对诊断和治疗的意义。
Int J Mol Sci. 2016 Dec 15;17(12):2113. doi: 10.3390/ijms17122113.
7
AT-406, an orally active antagonist of multiple inhibitor of apoptosis proteins, inhibits progression of human ovarian cancer.AT-406，一种口服活性的多凋亡抑制蛋白拮抗剂，可抑制人卵巢癌的进展。
Cancer Biol Ther. 2012 Jul;13(9):804-11. doi: 10.4161/cbt.20563. Epub 2012 Jun 6.
8
Effects of oral contraceptives or a gonadotropin-releasing hormone agonist on ovarian carcinogenesis in genetically engineered mice.口服避孕药或促性腺激素释放激素激动剂对基因工程小鼠卵巢癌发生的影响。
Cancer Prev Res (Phila). 2009 Sep;2(9):792-9. doi: 10.1158/1940-6207.CAPR-08-0236. Epub 2009 Sep 8.
9
Strategies for endometrial screening in the Lynch syndrome population: a patient acceptability study.林奇综合征人群的子宫内膜筛查策略：一项患者可接受性研究。
Fam Cancer. 2009;8(4):431-9. doi: 10.1007/s10689-009-9259-3. Epub 2009 Jun 13.
10
Cost-effectiveness of new tests to diagnose and treat coronary heart disease.用于诊断和治疗冠心病的新检测方法的成本效益。
Curr Treat Options Cardiovasc Med. 2005 Aug;7(4):273-86. doi: 10.1007/s11936-005-0038-7.